ATLANTA – InVasc, which is developing drugs to combat hardening of the arteries, has closed on $500,000 in seed capital, TechJournal South reported on Monday.
InVasc has patent protection on its compounds.
The company is led by Bobby Khan and Sam Parthasarathy, who are professors at Emory University.
